Related references
Note: Only part of the references are listed.The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type
Britta Weigelt et al.
JOURNAL OF PATHOLOGY (2010)
TRIPLE NEGATIVE BREAST CANCER - CURRENT STATUS AND PROSPECTIVE TARGETED TREATMENT BASED ON HER1 (EGFR), TOP2A AND C-MYC GENE ASSESSMENT
Katerina Bouchalova et al.
BIOMEDICAL PAPERS-OLOMOUC (2009)
Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal
S. Ward et al.
HEALTH TECHNOLOGY ASSESSMENT (2009)
Role of ErbB2 in selection for adjuvant tamoxifen or aromatase inhibitors
J. Michael Dixon
WOMENS HEALTH (2008)
Gene-expression pro-files to predict distant metastasis of lymph-node-negative primary breast cancer
YX Wang et al.
LANCET (2005)
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome
M van de Rijn et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Chromogenic in situ hybridization: A novel approach to a practical and sensitive method for the detection of HER2 oncogene in archival human breast carcinoma
N Dandachi et al.
LABORATORY INVESTIGATION (2002)
Share Paper
